PTPRD mutation was modestly associated with overall survival in melanoma and NSCLC cohorts (Fig. 5C, D), though this relationship was more significant than that between total mutational burden and overall survival (Fig. S1B). This evidence concerns the gene PTPRD and non-small cell lung carcinoma.